Hit discovery and hit-to-lead approaches

Area of Science:

• Drug Discovery and Development
• Medicinal Chemistry
• Pharmacology

Background:

• Hit discovery encompasses diverse methods like high-throughput screening, affinity selection, fragment-based techniques, and de novo design.
• Hit confirmation and hit-to-lead optimization are critical but challenging stages in drug development.
• The chosen hit discovery strategy significantly influences the subsequent hit-to-lead process.

Purpose of the Study:

• To summarize industry practices for addressing hit-to-lead challenges.
• To review how different hit discovery techniques affect hit-to-lead issues.
• To provide insights into optimizing the transition from hit discovery to lead development.

Main Methods:

• Literature review of common industry practices in hit-to-lead optimization.
• Analysis of advantages and drawbacks of various hit discovery technologies.
• Comparative assessment of how discovery methods influence hit-to-lead challenges.

Main Results:

• Common industry practices for hit-to-lead challenges are identified.
• The impact of specific hit discovery methods (e.g., HTS, fragment-based) on hit-to-lead issues is elucidated.
• A framework for understanding method-specific challenges in lead development is presented.

Conclusions:

• Effective hit-to-lead strategies depend on the initial hit discovery approach.
• Understanding the interplay between discovery methods and lead optimization is key for successful drug development.
• This review aids in selecting appropriate hit discovery techniques to mitigate downstream challenges.